These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7858850)

  • 21. Zatebradine slows ectopic ventricular rhythms in canine heart 24 hours after coronary artery ligation.
    Lasker SM; Han D; Kline RP
    J Cardiovasc Pharmacol; 1997 May; 29(5):662-9. PubMed ID: 9213210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heart rate and force-frequency effects on diastolic function of the left ventricle in exercising dogs.
    Miura T; Miyazaki S; Guth BD; Indolfi C; Ross J
    Circulation; 1994 May; 89(5):2361-8. PubMed ID: 8181162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of changing heart rate on electrophysiological and hemodynamic function in the dog.
    Hamlin RL; Nakayama T; Nakayama H; Carnes CA
    Life Sci; 2003 Mar; 72(17):1919-30. PubMed ID: 12597991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heart rate reduction by zatebradine reduces infarct size and mortality but promotes remodeling in rats with experimental myocardial infarction.
    Hu K; Naumann A; Fraccarollo D; Gaudron P; Kaden JJ; Neubauer S; Ertl G
    Am J Physiol Heart Circ Physiol; 2004 Apr; 286(4):H1281-8. PubMed ID: 15020301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Atenolol, its cardioselective property for adrenergic beta-receptor blocking action and effect on the cardiac function (author's transl)].
    Kanno M; Nakaya H; Hattori Y; Izumi T; Nishimura T; Sakai K; Abiko Y
    Nihon Yakurigaku Zasshi; 1980 Oct; 76(7):621-32. PubMed ID: 6111522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Zatebradine, a specific bradycardic agent, enhances the positive inotropic actions of dobutamine in ischemic myocardium.
    Wynsen JC; O'Brien PD; Warltier DC
    J Am Coll Cardiol; 1994 Jan; 23(1):233-41. PubMed ID: 8277087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Force-frequency effect is a powerful determinant of myocardial contractility in the mouse.
    Palakodeti V; Oh S; Oh BH; Mao L; Hongo M; Peterson KL; Ross J
    Am J Physiol; 1997 Sep; 273(3 Pt 2):H1283-90. PubMed ID: 9321817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of the specific bradycardic agent zatebradine on hemodynamic variables and myocardial blood flow during the early postresuscitation phase in pigs.
    Strohmenger HU; Wenzel V; Eberhard R; Guth BD; Lurie KG; Lindner KH
    Resuscitation; 1999 Nov; 42(3):211-20. PubMed ID: 10625162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute effects of zatebradine on cardiac conduction and repolarization.
    Sen L; Cui G; Zhou LM; Sakaguchi Y; Singh BN
    J Cardiovasc Pharmacol Ther; 2002 Jan; 7(1):29-38. PubMed ID: 12000976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of sinus node depression on heart rate variability in humans using zatebradine, a selective bradycardic agent.
    Khaykin Y; Dorian P; Tang A; Green M; Mitchell J; Wulffhart Z; Newman D
    Can J Physiol Pharmacol; 1998; 76(7-8):806-10. PubMed ID: 10030463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heart rate reduction by inhibition of If or by beta-blockade has different effects on postsystolic wall thickening.
    Lucats L; Ghaleh B; Colin P; Monnet X; Bizé A; Berdeaux A
    Br J Pharmacol; 2007 Feb; 150(3):335-41. PubMed ID: 17179940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A bradycardic agent, UL-FS 49, increases atrial force and decreases ventricular force in isolated, perfused heart preparations of dogs.
    Furukawa Y; Takayama S; Sawaki S; Inoue Y; Chiba S
    J Pharmacol Exp Ther; 1993 May; 265(2):801-6. PubMed ID: 8496825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use-dependent block of the pacemaker current I(f) in rabbit sinoatrial node cells by zatebradine (UL-FS 49). On the mode of action of sinus node inhibitors.
    Goethals M; Raes A; van Bogaert PP
    Circulation; 1993 Nov; 88(5 Pt 1):2389-401. PubMed ID: 8222132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of the intrinsic sympathomimetic activity of beta-adrenoceptor antagonists on haemodynamic effects in anaesthetized dogs.
    Wale JL; Austin M; Conway J; Reeves M
    Clin Exp Pharmacol Physiol; 1979; 6(1):11-9. PubMed ID: 32981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative study of coronary vasodilator and cardiac effects of nitrendipine by use of isolated, blood-perfused dog heart preparations.
    Satoh K; Wada Y; Taira N
    Arzneimittelforschung; 1986; 36(1):35-9. PubMed ID: 2937413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heart rate reduction during exercise-induced myocardial ischaemia and stunning.
    Monnet X; Colin P; Ghaleh B; Hittinger L; Giudicelli JF; Berdeaux A
    Eur Heart J; 2004 Apr; 25(7):579-86. PubMed ID: 15120055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Zatebradine, a specific bradycardic agent, alters the hemodynamic and left ventricular mechanical actions of levosimendan, a new myofilament calcium sensitizer, in conscious dogs.
    Pagel PS; Harkin CP; Hettrick DA; Warltier DC
    J Pharmacol Exp Ther; 1995 Oct; 275(1):127-35. PubMed ID: 7562540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of the subsidiary pacemaker activity by zatebradine, an If inhibitor, in the anesthetized dog heart.
    Yamazaki K; Furukawa Y; Nakano H; Kasama M; Imamura H; Chiba S
    J Cardiovasc Pharmacol; 1995 Dec; 26(6):957-64. PubMed ID: 8606534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of heart rate reduction in the treatment of exercise-induced myocardial ischaemia.
    Guth BD; Heusch G; Seitelberger R; Matsuzaki M; Ross J
    Eur Heart J; 1987 Dec; 8 Suppl L():61-8. PubMed ID: 3451884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of the novel anti-anginal compound RS 43285 on myocardial conduction in the anaesthetized dog.
    Allely MC; Alps BJ
    Br J Pharmacol; 1988 Feb; 93(2):375-82. PubMed ID: 3359110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.